Product Recalls in Louisiana

Product recalls affecting Louisiana — including food, drugs, consumer products, medical devices, and vehicles distributed to Louisiana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 954 recalls have been distributed to Louisiana in the last 12 months.

51,202 total recalls
954 in last 12 months

Showing 38861–38880 of 51,202 recalls

DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Morphine 25 mg/ml + Baclofen 100 mcg/ml Solution Recalled by The Compounding...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Testosterone 200 mg Anastrazole 1 mg Pellet Recalled by The Compounding...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Magnesium Chloride 200 mg/ml (20%) Injection Recalled by The Compounding...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Hydromorphone 70 mg/ml +Fentanyl 16 Recalled by The Compounding Pharmacy of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: HCG 5 Recalled by The Compounding Pharmacy of America Due to Lack of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Cyanocobalamin 10 mg Pellet Recalled by The Compounding Pharmacy of America...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Hyaluronidase 175 units/ml Injection Recalled by The Compounding Pharmacy of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Morphine 10 mg/ml Solution Recalled by The Compounding Pharmacy of America...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Hydromorphone 60 mg/ml + Fentanyl 7 Recalled by The Compounding Pharmacy of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Tri-Mix (30/1/10) (MFG) Injectable Recalled by The Compounding Pharmacy of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Lipo-B MMC I (SULFUR FREE) Injectable Recalled by The Compounding Pharmacy...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Clarithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Zonisamide capsules Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets Recalled by American Health Packaging Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets Recalled by American Health Packaging Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund